Unique ID issued by UMIN | UMIN000016573 |
---|---|
Receipt number | R000018975 |
Scientific Title | Real-time tumor-tracking proton beam therapy for prostate cancer |
Date of disclosure of the study information | 2015/02/26 |
Last modified on | 2020/08/25 23:25:43 |
Real-time tumor-tracking proton beam therapy for prostate cancer
Real-time tumor-tracking proton beam therapy for prostate cancer
Real-time tumor-tracking proton beam therapy for prostate cancer
Real-time tumor-tracking proton beam therapy for prostate cancer
Japan |
Prostate cancer
Urology | Radiology |
Malignancy
NO
To confirm the safety and efficacy of real-time tumor-tracking proton beam therapy for prostate cancer
Safety,Efficacy
Confirmatory
Pragmatic
Phase I,II
Incidence of early adverse effects within 90 days after real-time tumor-tracking proton beam therapy
Relapse free survival, incidence of adverse effect of Grade 3 or higher and cost-effectiveness at 18 months, incidence of dropout and migration of Au markers during treatment period
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
Real-time tumor-tracking proton beam therapy
20 | years-old | <= |
Not applicable |
Male
1) Pathologically proven adenocarcinoma of the prostate
2) ECOG-PS 0-2
3) Age 20-yrs old or over at the time of consent form is obtained
4) Well informed and documented consent from the patient
1) Pathologically proven non-adenocarcinoma or mixed type adenocarcinoma of the prostate
2) Clinically obvious lymph node or distant metastasis
3) With active other cancers
4) With severe uncontrolled diabetes
5) With severe heart disease, or some serious complications, i.e., SLE, Scleroderma
6) With an inflammatory bowel syndrome, i.e., Crohn's disease, ulcerative colitis
7) Previous surgical treatment or High-intensity focused ultrasound (HIFU) for prostate
8) Previous chemotherapy for prostate cancer before enrollment
9) Previous surgery to pelvis, except for appendectomy
10) Previous radiotherapy to pelvis
11) With implantable cardioverter defibrillator or permanent pacemaker
12) Allergic to radiation
13) Considered that participation in this trial is difficult because of psychiatric symptoms or psychosis
14) Cannot be held rest for about 30 minutes
15) Cannot be implanted Au marker in the prostate
16) Weight over 135 kg
17) Unsuitable for enrollment judged by principal investigator
45
1st name | Hiroki |
Middle name | |
Last name | Shirato |
Hokkaido University Graduate School of Medicine
Department of Radiation Medicine
060-8638
North 15 West 7, Kita-Ku, Sapporo, Hokkaido, Japan
+81-11-706-5977
shirato@med.hokudai.ac.jp
1st name | Shinichi |
Middle name | |
Last name | Shimizu |
Hokkaido University Graduate School of Medicine
Department of Radiation Medicine
060-8638
North 15 West 7, Kita-Ku, Sapporo, Hokkaido, Japan
+81-11-706-5977
sshing@med.hokudai.ac.jp
Department of Radiation Medicine, Hokkaido University Graduate School of Medicine
Ministry of Education, Culture, Sports, Science and Technology
Government offices of other countries
Japan
Hokkaido University Hospital Clinical Research and Medical Innovation Center
North 14 West 5, Kita-Ku, Sapporo, Hokkaido, Japan
+81-11-706-7636
crjimu@huhp.hokudai.ac.jp
NO
北海道大学病院(北海道)
2015 | Year | 02 | Month | 26 | Day |
Unpublished
45
Completed
2015 | Year | 01 | Month | 14 | Day |
2015 | Year | 02 | Month | 20 | Day |
2015 | Year | 02 | Month | 25 | Day |
2020 | Year | 02 | Month | 29 | Day |
2015 | Year | 02 | Month | 18 | Day |
2020 | Year | 08 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018975